Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenzae type B in patients with multiple myeloma. - Wikidata - awgldk - TriplyDB

Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenzae type B in patients with multiple myeloma.

Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenzae type B in patients with multiple myeloma.

http://www.wikidata.org/entity/Q36641621

about

Influenza vaccines in immunosuppressed adults with cancer Vaccines for prophylaxis of viral infections in patients with hematological malignancies Vaccines for prophylaxis of viral infections in patients with hematological malignancies Vaccination recommendations for the hematology and oncology and post-stem cell transplant populations Influenza vaccination in cancer patients undergoing systemic therapy Epidemiology of invasive pneumococcal infections: manifestations, incidence and case fatality rate correlated to age, gender and risk factors Influenza and Pneumococcal Vaccination in Hematological Malignancies: a Systematic Review of Efficacy, Effectiveness, and Safety Influenza vaccination for immunocompromised patients: systematic review and meta-analysis from a public health policy perspective How I treat influenza in patients with hematologic malignancies.The pandemic H1N1 influenza vaccine results in low rates of seroconversion for patients with hematological malignancies.Either interleukin-12 or interferon-gamma can correct the dendritic cell defect induced by transforming growth factor beta in patients with myeloma.Evaluation of vaccine dosing in patients with solid tumors receiving myelosuppressive chemotherapy.Efficacy of the influenza vaccine in patients with malignant lymphoma 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host.Transfer of influenza vaccine-primed costimulated autologous T cells after stem cell transplantation for multiple myeloma leads to reconstitution of influenza immunity: results of a randomized clinical trial.Immunization recommendations for adults with cancer.Influenza a outbreak in an ambulatory stem cell transplant center.Pneumococcal vaccination and revaccination of older adults.Comparative study of immune status to infectious agents in elderly patients with multiple myeloma, Waldenstrom's macroglobulinemia, and monoclonal gammopathy of undetermined significance.Immunogenicity of an inactivated monovalent 2009 influenza A (H1N1) vaccine in patients who have cancer Longitudinal analysis of tetanus- and influenza-specific IgG antibodies in myeloma patients.Idiotypic DNA vaccination for the treatment of multiple myeloma: safety and immunogenicity in a phase I clinical study.Risk of invasive Haemophilus influenzae type b (Hib) disease in adults with secondary immunodeficiency in the post-Hib vaccine era European Myeloma Network guidelines for the management of multiple myeloma-related complications.Antiviral prophylaxis in patients with haematological malignancies and solid tumours: Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Oncology (DGHO).Practical review of immunizations in adult patients with cancer.Influenza vaccine response in adults exposed to perfluorooctanoate and perfluorooctanesulfonate.Poor Correlation between Pneumococcal IgG and IgM Titers and Opsonophagocytic Activity in Vaccinated Patients with Multiple Myeloma and Waldenstrom's Macroglobulinemia.Baculovirus-expressed influenza vaccine. A novel technology for safe and expeditious vaccine production for human use.Immunodeficiency and immunotherapy in multiple myeloma.Immune therapies.Influenza vaccination in hematopoietic SCT recipients.Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses Dendritic cell vaccines for the immunocompromised patient: prevention of influenza virus infection.State-of-the-Art Management of Complications of Myeloma and Its Treatment.Guidelines for supportive care in multiple myeloma 2011.Using antimicrobial adjuvant therapy in cancer treatment: a review.Coinhibitory molecule PD-1 as a potential target for the immunotherapy of multiple myeloma.International Myeloma Working Group recommendations for global myeloma care.Pneumococcal immunization in immunocompromised hosts: where do we stand?

P2860

Q24202869-2A6D8BBB-692B-43FA-9D74-0A72553F100B Q24235812-DC0DF66E-E2E6-4C01-BC25-1B1971A493BE Q24245832-F276862F-89E6-47FD-87DC-0B8D8A1B6897 Q26829398-19819304-A318-40CB-9298-E18E0C1048A5 Q27027645-69109563-0E86-4142-91D5-27B24CB73716 Q27685556-5D04FB82-7FEC-4188-9403-9E8A0EAB5F5F Q28079486-2A673C02-7489-46F1-A23D-25B71023C198 Q28740919-E10C0AED-90B6-4F22-9981-75C30344C246 Q30383456-415F7987-EEB1-4752-8C09-701D6E0C4D87 Q30403660-71ACBCAE-99CC-4E8C-8DC6-930A64B72C7C Q33203486-FBF45484-A5C0-44A4-A274-4FF9E3586615 Q33259460-62868C16-F53D-4D1B-BEFA-60EFCE7423D1 Q34146495-1CF146D1-298B-4496-8A66-FA5887EF81E9 Q34390072-E68617E9-387A-406E-BD8D-073DD3C62877 Q34568939-F160D1E7-70E5-4E2E-8EE7-5D7B6DEC2AF6 Q34709861-97146DEC-7E8B-4CFF-8EEA-E45B94E6BBCA Q34801940-48E628CC-5DC7-4B5B-91D1-681C08A94F1A Q34926870-8603A476-BB7A-40EC-9B4C-6AFC021AC291 Q35066433-1CAE4D39-3F35-45BB-A7F1-D137E6AC2713 Q35705166-E38D938C-14AB-434D-A327-03DF38FCA3FD Q35846308-483C8C61-027F-4ABD-9B61-BCE0C6575EA7 Q35863376-BD0233C5-5D06-445F-A12E-FDF4CF00D489 Q35940648-ADA4C8FE-3287-432C-ACDC-7FBD0AED3984 Q36115636-55C8D336-BC6E-427D-93BB-EA99AFE6E3B0 Q36367268-14315187-8758-4C54-BFEA-D4C6880641DB Q36388960-EFEDC0FF-F507-480F-8AF2-D0B9D7CA94CC Q36493907-641E369E-A3A6-49F9-B5E8-4FF4A5AB194A Q36764389-604C0405-C9D2-4363-8EF1-52567035BA85 Q36861572-982C21ED-4734-4EC5-BCED-F9C38CA37F53 Q36904977-74A10C67-F0E1-4431-BD16-840D2F0007CA Q36998232-6BC05EB3-1B62-476F-9C8A-8F7540CFEE9F Q37251090-5FD2747F-80FC-4655-8FC6-BCD63A1DDCD2 Q37416103-E64E4517-FC33-4F2E-AF4B-906703BE479F Q37771941-6C670CC2-C8C3-4B24-99E6-F39C044A69A1 Q37776662-78BEDDFD-6B64-460C-A68E-C9286EAF694B Q37868637-E35B03C4-5CE5-4D40-A34E-1283C83B0F5E Q38060894-A0FE3AE0-1F4C-416E-ADC6-7EC84BA4D47B Q38155039-66C5422C-47D3-4DB3-A35C-39A9C760223D Q38157532-66E7315C-525A-4350-B9E6-80017362637C Q38168902-9327BFD6-75D1-47D6-95AD-E1C61B417B07

P2860

Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenzae type B in patients with multiple myeloma.

http://www.wikidata.org/entity/Q36641621

description

2000 nî lūn-bûn

@nan

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

2000年论文

@zh

2000年论文

@zh-cn

name

Immunogenicity of vaccination ...... atients with multiple myeloma.

@ast

Immunogenicity of vaccination ...... atients with multiple myeloma.

@en

type

label

Immunogenicity of vaccination ...... atients with multiple myeloma.

@ast

Immunogenicity of vaccination ...... atients with multiple myeloma.

@en

prefLabel

Immunogenicity of vaccination ...... atients with multiple myeloma.

@ast

Immunogenicity of vaccination ...... atients with multiple myeloma.

@en

P1433

Q36641621-93FE1F71-2EF8-421B-A478-4302227141BA

P1476

Q36641621-31006FF4-FBEE-45E5-8E16-AAD1B67D4C55

P2093

Q36641621-092B2B75-2DB1-4558-B7F8-827EDF2B6C3D

Q36641621-19F49D36-9539-4D6F-806E-AF653EA23347

Q36641621-27EF3ACD-E0E6-4623-9AB8-6AF6652E0122

Q36641621-2C029AF6-4B74-41DA-B02B-55EF5172F453

Q36641621-2E705F17-76B5-4A8D-AB43-0F57465E831B

Q36641621-8000449D-B1F1-496D-B361-561C2D054635

Q36641621-83701B0C-1C1A-4BD3-9096-2A5D83F2C96E

Q36641621-AF6328FE-0E49-417B-902E-93FC93E2D8D4

P2860

Q36641621-07666B92-03EB-45AA-AD0C-0937DDFAD2CD

Q36641621-0ED8D9D9-F5E6-4357-AEEF-702142BEBD72

Q36641621-113C2227-16A7-42E2-B998-06BF3AC6EDCF

Q36641621-2273B160-4D11-413C-81D6-1519136CA953

Q36641621-228CE424-0DD3-41B6-9BB1-B79B38613F8A

Q36641621-40BFF6A4-7B99-4AC2-A489-BF95EE344201

Q36641621-4B279C36-DA22-4BF8-8537-1EE0734125CD

Q36641621-512C6A8A-F9E1-492A-96AC-78CBD9753D5D

Q36641621-6CC41BEB-FF82-46D5-B7CB-D4682D8A9C0D

Q36641621-76C669D1-3784-4668-B88F-25EFA0A60939

P2888

Q36641621-08EEBF6E-B9EA-4202-BF31-EEDAE41EBC4C

P304

Q36641621-4800C551-8F95-42ED-BF52-22A3F5882356

P31

Q36641621-B454CFC3-E1C5-4F02-8067-8DD8BAAAE4BB

P356

Q36641621-DB750E78-DCCF-42B4-8AA5-6E9EFED176D9

P407

Q36641621-1AB3B1B5-1C19-4F7D-9162-6056C12C7B12

P433

Q36641621-E3D3E26E-479A-4853-9F59-1269530990FD

P478

Q36641621-C171775A-1379-4AB8-A2FF-7596BF166F24

P577

Q36641621-EAC589B3-70D6-469A-ABE0-CC1202FC87D5

P5875

Q36641621-30F32156-8A40-41E4-9FDC-DA3462298E84

P6179

Q36641621-807282DA-15A3-49CE-8784-6C51B6526E6B

P698

Q36641621-E682AD33-C89E-4EC3-B553-B80159CF25C4

P932

Q36641621-602F73A5-B53F-463C-B49A-5D435537BFB6

P356

P1433

British Journal of Cancer

P1476

Immunogenicity of vaccination ...... atients with multiple myeloma.

@en

P2093

Anderson H

http://www.w3.org/2001/XMLSchema#string

Dougal M

http://www.w3.org/2001/XMLSchema#string

Jowitt SN

http://www.w3.org/2001/XMLSchema#string

Mutton K

http://www.w3.org/2001/XMLSchema#string

Nagesh K

http://www.w3.org/2001/XMLSchema#string

Robertson JD

http://www.w3.org/2001/XMLSchema#string

Scarffe JH

http://www.w3.org/2001/XMLSchema#string

Zambon M

http://www.w3.org/2001/XMLSchema#string

P2860

Seroconversion after influenza vaccination in patients with lung cancer

Antigenic relationship between influenza B viruses.

Disseminated herpes simplex in untreated multiple myeloma. Paradox of present concepts of immune defects.

Reactions following administration of influenza vaccine alone or with pneumococcal vaccine to the elderly.

The severe combined immunodeficient (SCID) mouse as a model for the study of autoimmune diseases.

Allogeneic bone marrow transplantation for hematological malignancies--controversies and recent advances.

The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses.

Response to influenza virus vaccination in vertical HIV infection.

Antibody response to inactivated influenza vaccines of various antigenic concentrations.

Serological responses in volunteers to inactivated trivalent subunit influenza vaccine: antibody reactivity with epidemic influenza A and B strains and evidence of a rapid immune response.

P2888

P304

1261-1265

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1054/BJOC.1999.1088

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

82

http://www.w3.org/2001/XMLSchema#string

P577

2000-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12561808

http://www.w3.org/2001/XMLSchema#string

P6179

1048335389

http://www.w3.org/2001/XMLSchema#string

P698

10755398

http://www.w3.org/2001/XMLSchema#string

P932

2374477

http://www.w3.org/2001/XMLSchema#string